George Ng

George K.
Ng was the founder of Scilex Pharmaceuticals, Inc., founded in 2012, serving as President from 2012 to 2019.
Mr. Ng is the founder of IACTA Pharmaceuticals, Inc., founded in 2016, holding the title of Director & Chief Business Officer since 2020.
Mr. Ng is the founder of Peng Life Science Ventures, founded in 2013, serving as Partner since 2013.
Mr. Ng is currently Chief Executive Officer & Director at Processa Pharmaceuticals, Inc. since 2023.
Mr. Ng is currently Director at TuHURA Biosciences, Inc. (Old) since 2020.
Mr. Ng is currently Independent Director at TuHURA Biosciences, Inc. since 2024.
Former positions include Director at Inflammatory Response Research, Inc. from 2019 to 2020; Director at Virttu Biologics Ltd. from 2017 to 2019; Director at Immuneoncia Therapeutics, Inc. from 2016 to 2019; Director at Invent Medical Corp.
from 2019 to 2020; President, Chief Operating Officer & Director at Calidi Biotherapeutics (Nevada), Inc. from 2022 to 2023; Director at Calidi Biotherapeutics, Inc. from 2023 to 2024; Chief Compliance Officer & Head-Legal at Spectrum Pharmaceuticals, Inc. from 2007 to 2010; Senior Vice President & General Counsel at BioDelivery Sciences International, Inc. from 2012 to 2015; Secretary, Chief Legal Officer & Executive VP at Sorrento Therapeutics, Inc. in 2015; President at Pan Asian Lawyers of San Diego; Chief Legal Officer at Alpharma, Inc. Education includes undergraduate studies at the University of California, Davis and graduate studies at the University of Notre Dame The Law School.